Cell News and Research

RSS

Scientists discover immune pathway behind radiation-induced lung damage

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it.

20 Oct 2026

Targeted ultrasound waves safely reduce delusions in people with schizophrenia

Targeting a deep brain region with sound waves may safely reduce delusions in people with schizophrenia and schizoaffective disorder, initial study results show.

20 Oct 2026

Hunger may drive the propensity to develop alcohol addiction

Researchers at Brown University have discovered a molecular link between hunger and the formation of "reward" memories that play a role in alcohol addiction.

20 Oct 2026

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia.

20 Oct 2026

New gene-editing platform gives doctors control over cell therapies

An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.

20 Oct 2026

Scientists discover natural cellular defense mechanism against ALS progression

ALS is a disease where, in most cases, a protein forms aggregates in neurons, which leads to the rapid loss of motor control and death.

20 Oct 2026

New PET imaging approach detects nearly all kidney cancer lesions

A new PET imaging approach detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), potentially giving clinicians a more complete picture of the location and extent of a patient's disease, according to research presented today at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26).

20 Oct 2026

New study identifies protein factor linked to chronic liver disease

The mechanisms that cause the world's most common chronic liver disease — Metabolic dysfunction-associated steatotic liver disease (MASLD) — to develop and progress are not still fully understood.

20 Oct 2026

Study explores potential breast cancer benefits of neurokinin receptor antagonists

Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly effective nonhormone treatment.

20 Oct 2026

Could eating whey protein before meals help reduce blood sugar spikes?

A narrative review of 57 randomized trials found that milk and dairy products have inconsistent effects on long-term blood sugar control in adults with type 2 diabetes or prediabetes. Whey protein consumed before meals more consistently reduced short-term blood sugar spikes, but further research is needed to establish whether these benefits persist over time.

19 Oct 2026

Researchers use mitochondrial uncouplers to target breast cancer metastasis

Mitochondrial serine catabolic pathway (MSCP), also called serine, glycine, and one-carbon metabolism, is essential for cancer cells to produce amino acids, one-carbon units, and reducing equivalents.

19 Oct 2026

Study identifies initial cellular events in autoimmune kidney inflammation

When immunity works well, the body steers clear of infection and disease. However, when the immune system goes awry, healthy cells can often end up in the firing line.

19 Oct 2026

Study reveals mature immune functions in embryonic neutrophils

Neutrophils are white blood cells that form part of the body's first line of defence. Researchers have now demonstrated for the first time that neutrophils are found in many tissues during embryonic development, and that they can perform the same functions as adult neutrophils.

19 Oct 2026

Menopause isn't the end of the story for the ovaries

Research reveals that postmenopausal ovaries remain active, showing molecular remodeling linked to inflammation and potential implications for women's health.

19 Oct 2026

Silicone droplets or protein aggregates? Vision Analytical’s Raptor 1788 answers the prefilled syringe particle question at PDA Universe of Pre-Filled Syringes and Injection Devices 2026

Optimize subvisible particle analysis in prefilled syringes with the Raptor 1788, featuring high-resolution imaging and non-destructive testing capabilities.

From Vision Analytical Inc. 19 Oct 2026

Neurotechnology offers hope for better anxiety and depression treatments

Technology can contribute to better treatment for people struggling with anxiety and depression, according to researcher Sandra Klonteig.

16 Oct 2026

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

16 Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

16 Oct 2026

Scientists discover water-triggered reactions that may explain microplastic harm

Researchers found that six common types of microplastics spontaneously generate reactive oxygen species at their interfaces with water, with more hydrophobic plastics showing greater chemical activity. Laboratory experiments also linked these surface properties to biomolecular adsorption, protein aggregation, and mouse red blood cell damage, although the implications for human health remain uncertain.

15 Oct 2026

Scientists restore memory-linked neuron function in Alzheimer's mice

Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that mimic key features of Alzheimer's disease, showing early promise for the development of a similar targeted therapy in humans.

15 Oct 2026